Mike can’t retire because he wouldn’t be able to afford the cost of eye treatment that prevents him from going blind.
Read MoreMike can’t retire because he wouldn’t be able to afford the cost of eye treatment that prevents him from going blind.
Read MorePeople who live in rural and remote areas face real struggles to commit to start sight-saving eye injections and to stick with the treatment.
Read MoreMy eyes are our holiday money. I’ve even considered giving up my injections. It’s a
Read MoreMy Eyes offers a new way to support AMD patients.
Read MoreEvaluation of MDFA’s education courses for health professionals
Read MoreA years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.
Read MoreVabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
Read MoreMDFA 2022 research update
Read More